Low Tregs: A targetable risk factor for life-threatening cardiovascular complications after major noncardiac surgery.

Published in: Journal of leukocyte biology (2019)

Discussion on Tregs that have anti-inflammatory and anti-atherogenic properties as an ideal therapeutic target to reduce fatal cardiovascular deaths following major noncardiac surgery.

Keyphrases

minimally invasive
coronary artery bypass
anti inflammatory
surgical site infection
percutaneous coronary intervention
acute coronary syndrome